Three countries in Africa will receive the first Canadian-donated doses of the AstraZeneca vaccine – Nigeria (801,600 doses), Kenya (459,300) and Niger (100,800) – as part of an overall Canadian pledge of over 40 million doses to COVAX

The Gavi Board has approved the roll-out of RTS,S/AS01, the world’s first vaccine against malaria, a sickness which kills 260,000 children under five in sub-Saharan Africa every year. To get a sense of what this historic development might mean on…

New mRNA tech transfer hub to be established in South Africa. Facility will provide training and licences for vaccine development. Less than one per cent in Africa have been vaccinated against COVID-19.

Kenya is aiming to eliminate malaria entirely by 2030, with the world’s first malaria vaccine forming an important tool in its arsenal. The country’s youth is playing an important role.

A new study suggests the RTS,S malaria vaccine alone is as effective as preventive antimalarials; together they could save thousands of lives.

Community health volunteers collaborated with local structures in the slums to help inhabitants survive lockdown and stop the spread of disease.

For the Gosha community, vaccines are not only protecting them from COVID-19, but are also bringing development to their area.

Three countries in Africa will receive the first Canadian-donated doses of the AstraZeneca vaccine – Nigeria (801,600 doses), Kenya (459,300) and Niger (100,800) – as part of an overall Canadian pledge of over 40 million doses to COVAX

The first shipments of a 3 million dose pledge to COVAX thus far by Greece have arrived in Kenya (376,800 doses) and Syria (144,000). This builds on previous funding commitments of EUR 1.5 million to the Gavi COVAX Advance Market Commitment (Gavi…